scispace - formally typeset
H

Hyung Jun Ahn

Researcher at Korea Institute of Science and Technology

Publications -  43
Citations -  5420

Hyung Jun Ahn is an academic researcher from Korea Institute of Science and Technology. The author has contributed to research in topics: Gene silencing & Small interfering RNA. The author has an hindex of 18, co-authored 43 publications receiving 4257 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA.

TL;DR: The superior efficiency of the siRNA/capsid nanocarrier complexes in RFP gene silencing, compared to untreated cells is demonstrated, providing an alternative approach to enhancing the stability of siRNA as well as to achieving targeted siRNA delivery.
Journal ArticleDOI

Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo.

TL;DR: By targeting this OA biomarker, the symptoms of the early and late stages of OA can be readily monitored, imaged, and analyzed in a rapid and efficient fashion, and this simple and highly efficient fluorogenic probe will assist in the clinical management of patients with OA.
Journal ArticleDOI

CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.

TL;DR: Haluronic acid-labeled poly(d,l-lactide-co-glycolide) nanoparticle encapsulating both paclitaxel (PTX) and focal adhesion kinase (FAK) siRNA as a selective delivery system against chemoresistant ovarian cancer demonstrates the efficacy of a novel, selective, two-in-one delivery system to overcome chemoresistance in epithelial ovarian cancer.
Journal ArticleDOI

Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription.

TL;DR: This strategy allows the design of a platform technology for systemic delivery of siRNA to tumour sites, because RCT reaction, which enzymatically generates RNA polymers in multiple copy numbers at low cost, can lead to directly accessible routes to targeted and systemic delivery.